2018
DOI: 10.1111/pace.13485
|View full text |Cite
|
Sign up to set email alerts
|

The effect of statins on the recurrence rate of atrial fibrillation after catheter ablation: A meta‐analysis

Abstract: Statin use was associated with a significantly lower AF recurrence rate in RCTs but not in the whole analysis and the observational studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 28 publications
1
11
1
Order By: Relevance
“…Rosuvastatin significantly reduced risk of incident AF, compared with placebo, in a large (17,000 patients) exploratory analysis of the JUPITER trial, 123 and statin therapy was associated with lower recurrence of AF and burden following dual-chamber pacemaker implantation in 185 patients with paroxysmal AF. 124 The role of statins in prevention of AF was further shown in a metaanalysis by Fang et al 125 Although our previous randomized controlled trial of highintensity atorvastatin therapy for prevention of atrial fibrillation postpulmonary catheter ablation was negative (125 patients), 126 a very recent meta-analysis rate in 4 pooled randomized controlled trials (488 patients), including ours, 127 did show that statins significantly lowered recurrence of AF postcatheter ablation. Accordingly, large-scale, high-quality randomized controlled clinical trials investigating statins and other common therapeutic targets for both AF primary or secondary prevention and endothelial function improvement are certainly warranted.…”
Section: Af Endothelial Dysfunction and Strokementioning
confidence: 67%
“…Rosuvastatin significantly reduced risk of incident AF, compared with placebo, in a large (17,000 patients) exploratory analysis of the JUPITER trial, 123 and statin therapy was associated with lower recurrence of AF and burden following dual-chamber pacemaker implantation in 185 patients with paroxysmal AF. 124 The role of statins in prevention of AF was further shown in a metaanalysis by Fang et al 125 Although our previous randomized controlled trial of highintensity atorvastatin therapy for prevention of atrial fibrillation postpulmonary catheter ablation was negative (125 patients), 126 a very recent meta-analysis rate in 4 pooled randomized controlled trials (488 patients), including ours, 127 did show that statins significantly lowered recurrence of AF postcatheter ablation. Accordingly, large-scale, high-quality randomized controlled clinical trials investigating statins and other common therapeutic targets for both AF primary or secondary prevention and endothelial function improvement are certainly warranted.…”
Section: Af Endothelial Dysfunction and Strokementioning
confidence: 67%
“…More methods of obtaining valid MR estimates when using invalid instruments are required. [38] on IHD, stroke and AF using Mendelian randomization applied to the CARDIoGRAMplusC4D 1000 Genomes based GWAS of IHD [39], UK Biobank summary statistics from SAIGE for IHD and stroke [42], MEGASTROKE [40] for stroke and a study by Nielsen et al [41] for AF and the effects of statins and PCSK9 inhibitors on the same outcomes from meta-analysis of RCTs [30,32,36,37] Estimates from…”
Section: Resultsmentioning
confidence: 99%
“…Statins and PCSK9 inhibitors are well-established interventions for cardiovascular disease, which reduce low density lipoprotein (LDL)-cholesterol, IHD [29][30][31], stroke [29][30][31] and atrial fibrillation (AF) [32].…”
Section: Illustrative Examplementioning
confidence: 99%
See 1 more Smart Citation
“…It is associated with B-type natriuretic peptide levels (BNP), adiponectin, insulin, and free fatty acids. Studies have shown that surgical epicardial LAA closure can lead to downregulation of the adrenergic system and RAAS ( 29 , 30 ).…”
Section: Discussionmentioning
confidence: 99%